Our Team

Staff at the Cancer Research Institute’s headquarters in New York City hold special expertise in nonprofit management and development, scientific and medical communications, event planning, and grants administration. Our team is passionate about saving more lives with cancer immunotherapy.

CEO

Jill O’Donnell-Tormey, PhD, is the chief executive officer and director of scientific affairs at the Cancer Research Institute (CRI), a global nonprofit organization dedicated to advancing the most promising areas of cancer immunotherapy research to harness the power of the immune system to conquer and cure all cancers. During her tenure at CRI, she has spearheaded the creation of catalytic and novel research programs that span the laboratory and the clinic. She has guided over $500 million in funding to these programs, which enable research and scientific discovery that is changing the course of cancer treatment and saving more lives today.

Our People

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.